| Greenwich Village Gastroenterology, P.c. | |
|
55 Montgomery St Poughkeepsie NY 12601-4106 | |
| (845) 471-1354 | |
| (845) 689-0610 |
| Full Name | Greenwich Village Gastroenterology, P.c. |
|---|---|
| Speciality | Internal Medicine |
| Location | 55 Montgomery St, Poughkeepsie, New York |
| Authorized Official Name and Position | Anthony A Starpoli (PRESIDENT) |
| Authorized Official Contact | 8454711354 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Greenwich Village Gastroenterology, P.c. 55 Montgomery St Poughkeepsie NY 12601-4106 Ph: (845) 471-1354 | Greenwich Village Gastroenterology, P.c. 55 Montgomery St Poughkeepsie NY 12601-4106 Ph: (845) 471-1354 |
| NPI Number | 1053495507 |
|---|---|
| Provider Enumeration Date | 10/24/2006 |
| Last Update Date | 07/22/2009 |
| Medicare PECOS PAC ID | 0042314122 |
|---|---|
| Medicare Enrollment ID | O20070329000282 |
News Archive
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Clinical Data, Inc., and Santen Pharmaceutical Co., Ltd., today announced that Santen has exercised its option to license Clinical Data's highly selective adenosine A2A agonist compound, ATL313, for the development of topical treatments for certain ophthalmic diseases, including glaucoma. ATL313, a promising late-stage preclinical compound, has shown significant pharmacological effects in vivo and has been nominated as a clinical candidate.
Have you ever reached the end of a holiday buffet with a plate filled with more food than you intended?
A new study has shown there is an urgent need for more children to take part in clinical trials to make sure medicines can be licensed for their safe and effective use.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053495507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
| Provider Name | Anthony A Starpoli |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1477633642 PECOS PAC ID: 9032109442 Enrollment ID: I20040517001181 |
News Archive
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Clinical Data, Inc., and Santen Pharmaceutical Co., Ltd., today announced that Santen has exercised its option to license Clinical Data's highly selective adenosine A2A agonist compound, ATL313, for the development of topical treatments for certain ophthalmic diseases, including glaucoma. ATL313, a promising late-stage preclinical compound, has shown significant pharmacological effects in vivo and has been nominated as a clinical candidate.
Have you ever reached the end of a holiday buffet with a plate filled with more food than you intended?
A new study has shown there is an urgent need for more children to take part in clinical trials to make sure medicines can be licensed for their safe and effective use.
› Verified 7 days ago
News Archive
Patient assessment of clinical services quality was shown to be an independent predictor of survival for colorectal cancer patients in a study recently published in the Journal of Healthcare Quality, the peer reviewed publication of the National Association for Healthcare Quality (NAHQ), www.nahq.org.
Clinical Data, Inc., and Santen Pharmaceutical Co., Ltd., today announced that Santen has exercised its option to license Clinical Data's highly selective adenosine A2A agonist compound, ATL313, for the development of topical treatments for certain ophthalmic diseases, including glaucoma. ATL313, a promising late-stage preclinical compound, has shown significant pharmacological effects in vivo and has been nominated as a clinical candidate.
Have you ever reached the end of a holiday buffet with a plate filled with more food than you intended?
A new study has shown there is an urgent need for more children to take part in clinical trials to make sure medicines can be licensed for their safe and effective use.
› Verified 7 days ago
Anthony R Tardio Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Fulton Ave, Poughkeepsie, NY 12603 Phone: 845-471-5070 Fax: 845-471-8901 | |
Mahboobur Rahman Md & Gopa Rahman Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 243 North Rd, Suite 201n, Poughkeepsie, NY 12601 Phone: 845-454-0370 Fax: 845-454-6017 | |
Hudson Valley Medical Doctors Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14 Raymond Ave, Poughkeepsie, NY 12603 Phone: 845-471-5519 Fax: 845-471-2928 | |
Long Term Care Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-483-6217 Fax: 845-483-6108 | |
Nunziata Raschella Md Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 97 Fulton Ave, Poughkeepsie, NY 12603 Phone: 845-486-7520 Fax: 845-486-8090 | |
Hudson Valley Emergency Medicine Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Place, Vassar Brothers Medical Center, Poughkeepsie, NY 12601 Phone: 845-431-5624 Fax: 610-617-6280 |